Arteris, Inc.
Business
Arteris, Inc. provides semiconductor system IP that manages on‑chip communications for complex system-on-chip (SoC) semiconductors and systems of chiplets. It offers Network‑on‑Chip (NoC) interconnect IP, NoC interface IP (e.g., last‑level cache, memory scheduler, debug), and SoC Integration Automation (SIA) software for IP packaging, register management, and hardware‑software integration. The company’s business is organized around interconnect IP product lines (FlexGen/FlexNoC/FlexWay, Ncore, CodaCache) and SIA solutions from Magillem and CSRCompiler. Arteris serves global semiconductor customers across automotive, enterprise computing, communications, consumer electronics, and industrial markets via direct sales, engineering support, and partnerships with IP and EDA providers.
Summary from filing dated 2025-02-18
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenue | 71 | 58 | 54 | 50 | 38 | |
| Cost of revenue | 7 | 6 | 5 | 4 | 4 | |
| Gross profit | 64 | 52 | 49 | 46 | 34 | |
| Research and development | 50 | 45 | 45 | 41 | 31 | |
| Sales and marketing | 27 | 21 | 21 | 17 | 12 | |
| General and administrative | 20 | 18 | 18 | 16 | 13 | |
| Total operating expenses | 97 | 83 | 84 | 75 | 56 | |
| Loss from operations | −33 | −32 | −35 | −29 | −22 | |
| Interest expense | −193,000 | −244,000 | −211,000 | — | — | |
| Other income (expense), net | 3 | 3 | 4 | 1 | −474,000 | |
| Loss before income taxes and loss from equity method investment | −30 | −28 | −32 | −28 | −22 | |
| Loss from equity method investment, net of tax | 3 | 3 | 3 | 284,000 | 0 | |
| Loss before provision for income taxes | −33 | −31 | — | — | −22 | |
| Provision for income taxes | 1 | 3 | 2 | −417,000 | 1 | |
| Net loss | −35 | −34 | −37 | −27 | −23 | |
| Net loss per share attributable to common stockholders, basic (in dollars per share) | −0.82 | −0.86 | −1.03 | −0.84 | −1.06 | |
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | −0.82 | −0.86 | −1.03 | −0.84 | −1.06 | |
| Weighted average shares used in computing per share amounts, basic (in shares) | 42 | 39 | 36 | 33 | 22 | |
| Weighted average shares used in computing per share amounts, diluted (in shares) | 42 | 39 | 36 | 33 | 22 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 34 | 14 | 14 | 37 | 86 | |
| Short-term investments (Note 5) | 21 | 30 | 27 | 31 | 0 | |
| Accounts receivable, net of allowance of $73 and $131 as of December 31, 2025, and 2024, respectively | 19 | 21 | 12 | 7 | 14 | |
| Prepaid expenses and other current assets | 9 | 5 | 5 | 6 | 7 | |
| Total current assets | 82 | 69 | 58 | 81 | 107 | |
| Property and equipment, net | 4 | 4 | 6 | 4 | 2 | |
| Long-term investments (Note 5) | 5 | 9 | 12 | 4 | 0 | |
| Equity method investment | 3 | 6 | 9 | 12 | 0 | |
| Operating lease right-of-use assets | 4 | 4 | 4 | 2 | 3 | |
| Intangibles, net | 2 | 3 | 4 | 5 | 3 | |
| Goodwill | 4 | 4 | 4 | 4 | 3 | |
| Other assets | 11 | 8 | 6 | 4 | 3 | |
| TOTAL ASSETS | 115 | 106 | 103 | 116 | 120 | |
| Accounts payable | 340,000 | 539,000 | 183,000 | 572,000 | 2 | |
| Accrued expenses and other current liabilities | 19 | 16 | — | — | — | |
| Operating lease liabilities, current | 1 | 917,000 | 781,000 | 899,000 | 961,000 | |
| Deferred revenue, current | 51 | 40 | 32 | 29 | 28 | |
| Vendor financing arrangements, current | 1 | 1 | 2 | 1 | 833,000 | |
| Total current liabilities | 73 | 59 | 46 | 44 | 42 | |
| Deferred revenue, noncurrent | 44 | 35 | 25 | 22 | 21 | |
| Operating lease liabilities, noncurrent | 3 | 3 | 4 | 1 | 2 | |
| Vendor financing arrangements, noncurrent | 452,000 | 594,000 | 1 | 448,000 | 266,000 | |
| Deferred income, noncurrent | 6 | 8 | 9 | 10 | 0 | |
| Other liabilities | 2 | 2 | 2 | 1 | 2 | |
| Total liabilities | 130 | 107 | 88 | 78 | 68 | |
| Commitments and contingencies (Note 11) | — | — | — | — | — | |
| Preferred stock, par value of $0.00110,000,000 shares authorized and no shares issued and outstanding as of both December 31, 2025, and 2024 | 0 | 0 | 0 | 0 | 0 | |
| Common stock, par value of $0.001300,000,000 shares authorized at December 31, 2025, and 2024; 44,268,816 and 40,724,936 shares issued and outstanding at December 31, 2025, and 2024, respectively | 44,000 | 40,000 | 37,000 | 34,000 | 31,000 | |
| Additional paid-in capital | 157 | 136 | 118 | 104 | 92 | |
| Accumulated other comprehensive income | 179,000 | 135,000 | 120,000 | 101,000 | −81,000 | |
| Accumulated deficit | −172 | −137 | −103 | −66 | −39 | |
| Total stockholders deficit | −15 | −1 | 15 | 38 | 53 | |
| TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT | 115 | 106 | 103 | 116 | 120 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 3 | 3 | 3 | 2 | 1 | |
| Stock-based compensation | 18 | 16 | 15 | 12 | 6 | |
| Pension plan expenses | 201,000 | 163,000 | 134,000 | 136,000 | 109,000 | |
| Amortization of deferred income | −1 | −1 | −1 | −391,000 | 0 | |
| Net accretion of discounts on available-for-sale securities | −368,000 | −695,000 | −893,000 | −177,000 | 0 | |
| Other, net | 401,000 | −9,000 | 128,000 | 14,000 | −9,000 | |
| Accounts receivable, net | 1 | −9 | −5 | 7 | 477,000 | |
| Prepaid expenses and other assets | −6 | −1 | −1 | 202,000 | −4 | |
| Accounts payable | −191,000 | 324,000 | −389,000 | −1 | 350,000 | |
| Accrued expenses and other liabilities | 3 | 3 | 2 | 517,000 | 3 | |
| Deferred revenue | 20 | 19 | 6 | 830,000 | 16 | |
| Net cash provided by (used in) operating activities | 7 | −720,000 | −16 | −7 | −814,000 | |
| Purchases of property and equipment | −1 | −324,000 | −2 | −1 | −808,000 | |
| Purchases of available-for-sale securities and other | −30 | −37 | −48 | −35 | 0 | |
| Proceeds from maturities and sales of available-for-sale securities and other | 43 | 38 | 45 | 0 | — | |
| Net cash provided by investing activities | 12 | 970,000 | −5 | −37 | −1 | |
| Principal payments under vendor financing arrangements | −2 | −2 | −1 | −1 | −574,000 | |
| Proceeds from exercise of stock options | 2 | 890,000 | 500,000 | 900,000 | 600,000 | |
| Proceeds from employee stock purchase plan | 982,000 | 538,000 | 0 | — | — | |
| Other financing activities | 72,000 | 59,000 | 79,000 | 0 | 0 | |
| Net cash provided by (used in) financing activities | 1 | −262,000 | −3 | −4 | 76 | |
| NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | 20 | −12,000 | −23 | −48 | 74 | |
| Cash paid for taxes | 3 | 2 | 1 | 790,000 | 489,000 | |
| Accrued deferred offering costs | 522,000 | 0 | — | — | — | |
| Operating lease right-of-use assets exchanged for lease liabilities | 1 | 464,000 | 3 | 63,000 | 0 | |
| Purchase of property and equipment through vendor financing | 2 | 546,000 | 3 | 2 | 1 |